drugset / Trial / NCT07366866
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
RandomizedParallel-groupDouble-blindOther
Summary
This study is designed to evaluate the safety, tolerability, PK and PD of GenSci136 in a randomized, double-blind, placebo-controlled trial involving healthy adult participants.
Timeline
- Start
- 2026-03-16
- Primary completion
- 2027-02-07
- Completion
- 2027-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci136 | Unknown | — | Subcutaneous |